How can the study of familial leukemias help us to understand sporadic leukemias?
Jane E. Churpek
Improving T-cell therapy with antigen specific T-cells
Results of trial of vadastuximab talirine plus hypomethylating agents in AML
Progress in the development of treatments for leukemia
Benefits of deacetylase inhibitors for leukemia therapy